Related Experiment Video
Updated: Jan 15, 2026
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Future Directions in Imaging Neurodegeneration.
1Nantz National Alzheimer Center and Neuroimaging, Houston Methodist Neurological Institute, Houston Methodist Hospital, New York Medical College, Weill Medical College of Cornell University, 6560 Fannin Street, Scurlock 802, Houston, TX, 77030, USA. jcmasdeu@houstonmethodist.org.
Neuroimaging techniques like MRI and PET are crucial for diagnosing and understanding neurodegenerative diseases. These tools track brain changes, metabolism, and key markers like amyloid and tau, aiding in treatment monitoring and research for conditions such as Alzheimer's disease.
Area of Science:
- Neuroimaging
- Neurodegenerative Disorders
- Neurobiology
Background:
- Neuroimaging tools are vital for diagnosing neurodegenerative disorders.
- They clarify neurobiology and monitor treatment efficacy.
- Techniques like MRI and PET offer insights into brain structure, function, and metabolism.
Purpose of the Study:
- To highlight the role of neuroimaging in diagnosing and understanding neurodegenerative diseases.
- To emphasize the utility of MRI and PET in monitoring disease progression and treatment.
- To discuss the application of neuroimaging in studying key biomarkers like amyloid and tau.
Main Methods:
- Magnetic Resonance Imaging (MRI) for volume, functional, and structural connectivity analysis.
- Positron Emission Tomography (PET) for regional cerebral metabolism, neurotransmitter quantification, and biomarker imaging (amyloid-β, tau, inflammation).
- In vivo quantification and longitudinal follow-up of neurobiological events.
Main Results:
- MRI depicts brain volume changes and connectivity abnormalities.
- PET quantifies cerebral metabolism, neurotransmitter levels (e.g., dopamine), and pathological protein deposition (amyloid-β, tau).
- Neuroimaging enables in vivo measurement and longitudinal tracking of neurodegenerative processes.
Conclusions:
- Neuroimaging is indispensable for diagnosing and managing neurodegenerative disorders.
- PET and MRI provide critical data for understanding disease mechanisms and evaluating therapeutic interventions.
- Amyloid imaging shows promise in Alzheimer's disease research for assessing treatment efficacy and disease modification.
